# Crestone, Inc.

Canonical: https://abierto.us/vendors/crestone-inc-edslap2j1bl8

- UEI: EDSLAP2J1BL8
- CAGE: 5RDJ6
- Location: Boulder, CO
- Awards in window: 2 (7 transactions), $4,667,159 obligated, January 7, 2026 to August 31, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, $4,667,159

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $3,501,414
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $1,165,745

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75N93020C00020 (definitive contract): $3,501,414, National Institutes of Health Niaid. To Advance a Promising, Small-Molecule Compound CRS0540 to Ind Filing and Through Phase I Clinical Studies.. https://www.usaspending.gov/award/CONT_AWD_75N93020C00020_7529_-NONE-_-NONE-/
- 75N93019C00056 (definitive contract): $1,165,745, National Institutes of Health Niaid. To Perform the Evaluation of Safety and Efficacy of CRS3123 to Treat Clostridium Difficile Infections.. https://www.usaspending.gov/award/CONT_AWD_75N93019C00056_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/crestone-inc-edslap2j1bl8.